{"slug":"ss-31-benzodiazepines","verification":{"valid":true,"entries":2,"head":"f7ea6f12e18b0b0b677c98d8f1f46c6cbb3a1bc9ae6b8f340afcb7595b1b984d"},"energy":{"passes":2,"tokens_in":15978,"tokens_out":2979,"tokens_total":18957,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"f7ea6f12e18b0b0b677c98d8f1f46c6cbb3a1bc9ae6b8f340afcb7595b1b984d"},"provenance":[{"ts":"2026-06-29T23:59:51.988Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Benzodiazepines\nSlug: ss-31-benzodiazepines\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Benzodiazepines\",\"condition_key\":\"benzodiazepines\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[\"benzodiazepines\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Benzodiazepines\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Benzodiazepines** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Benzodiazepines** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"benzodiazepines\",\"name\":\"Benzodiazepines\",\"section_title\":\"Why Benzodiazepines matters for you\",\"steps\":[\"**Drug:** Benzodiazepines\",\"**What it does:** GABAergic suppression; does not rebuild neurochemistry.\",\"**Therefore for you:** state whether this drug **reduces load**, ","response":"{\n  \"slug\": \"ss-31-benzodiazepines\",\n  \"title\": \"SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame\",\n  \"body\": \"## What's breaking down if you have Benzodiazepines\\n\\nLong-term benzodiazepine exposure involves chronic enhancement of GABA-A receptor activity. This leads to receptor downregulation and tolerance over time. Neuronal energy demands stay high while signaling adapts downward. Mitochondrial function in brain cells can decline because sustained GABAergic tone alters calcium handling and increases oxidative load in some models. If mitochondrial ATP production falls behind, repair of synapses and receptors slows. The result is a state where the original problem persists even if the drug is tapered, because breakdown outpaces cellular restoration.\\n\\nBenzodiazepines themselves do not rebuild receptor density or mitochondrial capacity. They suppress acute signals. That distinction matters when the goal is long-term neurochemical stability.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about Benzodiazepines — what breaks down matters before any compound name.\\n2. Therefore for you: If mitochondrial dysfunction in neurons forms part of the load after prolonged use, SS-31 (Elamipretide) is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms or directly modulates GABA receptors.\\n\\nSS-31 binds cardiolipin. This stabilizes the inner membrane, supports electron transport chain efficiency, and lowers excess reactive oxygen species. In a repair frame, better mitochondrial output could supply the ATP needed for receptor trafficking and synaptic maintenance once the suppressive drug load changes. No direct if-then data exists for benzodiazepine contexts, so the logic stays mechanistic.\\n\\n## Why Benzodiazepines matters for you\\n\\nDrug: Benzodiazepines.\\nWhat it does: GABAergic enhancement that suppresses excitatory signaling; does not rebuild receptor ","tokens_in":15978,"tokens_out":2979,"cost":0,"prev":"genesis","hash":"81f1ff0e4d5ac9911f5a8c2307b0c80c49bccf88d78247d275f64b7c6c2139db"},{"ts":"2026-07-17T02:42:01.195Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-benzodiazepines","response":"27 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"81f1ff0e4d5ac9911f5a8c2307b0c80c49bccf88d78247d275f64b7c6c2139db","hash":"f7ea6f12e18b0b0b677c98d8f1f46c6cbb3a1bc9ae6b8f340afcb7595b1b984d"}]}